This inventor holds 1 USPTO granted patent. Top assignee: University of Utah Research Foundation. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Katherine Updike: Innovator in Cancer Research
Introduction
Katherine Updike is a prominent inventor based in Salt Lake City, UT (US). She has made significant contributions to the field of cancer research, particularly in the development of innovative diagnostic methods. Her work focuses on assessing the risk of cancer recurrence, which is crucial for improving patient outcomes.
Latest Patents
Katherine Updike holds a patent for a multigene assay designed to assess the risk of recurrence of cancer. This patent includes biomarkers and methods for determining the risk of cancer recurrence in a subject. The methods involve determining the level of expression of at least one MHCII gene, assessing the level of expression of at least one TIL gene, and calculating an Immune Activation Score for the subject. Additionally, her patent provides methods for diagnosing triple-negative breast cancer (TNBC) as having the TNBC Basal-like subtype, along with methods for treating cancer in a subject.
Career Highlights
Katherine Updike is affiliated with the University of Utah Research Foundation, where she continues to advance her research in cancer diagnostics and treatment. Her innovative approach has the potential to significantly impact the way cancer recurrence is assessed and managed.
Collaborations
Katherine has collaborated with notable colleagues, including Katherine (k-t) E Varley and Rachel L Stewart. These collaborations enhance the research efforts and contribute to the development of effective cancer treatment strategies.
Conclusion
Katherine Updike's work exemplifies the vital role of innovation in cancer research. Her contributions through her patent and collaborations are paving the way for improved diagnostic methods and treatment options for cancer patients.